International Medical Insurance

March 29, 2023

FDA Approves First Over-the-Counter Naloxone Nasal Spray

March 29, 2023, the U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription use – the first naloxone product approved for use without a prescription. Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard treatment for opioid overdose.
March 29, 2023

NEWLY APPROVED INDICATIONS

March 29, 2023 - The FDA approved Emergent BioSolutions’ Narcan (naloxone hydrochloride) 4 mg nasal spray as an over-the-counter (OTC) emergency treatment for opioid overdose
March 24, 2023

FDA Approves Joenja

March 24, 2023 - Pharming Group N.V. has announced that the US Food and Drug Administration (FDA) has approved Joenja® (leniolisib) for the treatment of activated phosphoinositide